Print Options

Card layout: ?

← Back to notecard set|Easy Notecards home page

Instructions for Side by Side Printing
  1. Print the notecards
  2. Fold each page in half along the solid vertical line
  3. Cut out the notecards by cutting along each horizontal dotted line
  4. Optional: Glue, tape or staple the ends of each notecard together
  1. Verify Front of pages is selected for Viewing and print the front of the notecards
  2. Select Back of pages for Viewing and print the back of the notecards
    NOTE: Since the back of the pages are printed in reverse order (last page is printed first), keep the pages in the same order as they were after Step 1. Also, be sure to feed the pages in the same direction as you did in Step 1.
  3. Cut out the notecards by cutting along each horizontal and vertical dotted line
To print: Ctrl+PPrint as a list

35 notecards = 9 pages (4 cards per page)

Viewing:

SWM Module 22: Wound Care — Pediatric and Neonatal Considerations

front 1

Which factor is MOST likely to impair collagen formation and cell proliferation in children?

Vitamin C deficiency

Incorrectly unselected

Zinc deficiency

Correctly unselected

Protein deficiency

Incorrectly selected

Poor circulation

back 1

Vitamin C deficiency

* Vitamin C, along with vitamins B and D, is essential for collagen synthesis and cellular proliferation. A deficiency in vitamin C directly impairs collagen formation, which delays wound healing.

front 2

Affects from zinc deficiency

back 2

Primarily affects epithelialization, which helps close and cover a wound. While this delays wound closure, it does not directly impact collagen formation

front 3

Affects from protein deficiency

back 3

Hinders overall tissue repair and cell growth, reducing the body’s ability to rebuild tissue. Although protein is important for wound healing, it is not specifically involved in collagen synthesis.

front 4

How does poor circulation affect wound healing?

back 4

By restricting oxygen and nutrient delivery, which are necessary for all stages of wound healing, but it does not specifically interfere with collagen formation.

front 5

For neonates what dressings would you avoid?

back 5

Hydrogels if they are in incubator setting

Alignate dressings d/t entering system and compromising bloodstream

front 6

What does IAD stand for in wound mgt.

back 6

Incontinence-associated dermatitis, or diaper dermatitis, has the highest incidence between 7 and 12 months of age (Lund & Singh, 2022).

front 7

IAD Treatment

back 7

Use a non-irritating, pH-balanced wipe/cleanser, or tepid tap water to clean the diaper area gently without causing further irritation (Lund & Singh, 2022). Then, apply a zinc oxide or petrolatum-based barrier cream to create a protective layer.

Keeping the damaged skin moist is essential to promoting healing, so do not fully remove the protective cream already applied. Remove only the layers contaminated with stool, and then generously reapply the cream.

front 8

Candida albicans,

back 8

a pathogenic yeast, presents as bright red areas of dermatitis with distinct boundaries and surrounding satellite lesions, typically involving the inguinal folds. Treatment for Candida infections requires an antifungal agent, such as nystatin or imidazoles (e.g., miconazole [Lotrimin®]).

front 9

The recommended treatment protocol for Candida infection with skin denuding includes:

back 9

  • Applying an antifungal powder
  • Applying a skin protectant
  • Applying zinc oxide cream

front 10

(MARSI)

back 10

medical adhesive-related skin injury

front 11

MARSI Treatment

back 11

To treat MARSI, gently clean the area with a pH-balanced cleanser and carefully dry it. Next, apply a silicone-based dressing (e.g., Mepitel®), as it protects the wound without adhering to it and causes minimal tissue damage during removal.

front 12

MARSI Prevention

The prevention of MARSI includes the preferred use of the following:

back 12

  • Silicone-Based Products Silicone-based products are gentler and safer for sensitive skin.
    • Sensi-Care™ Sting Free Adhesive Releaser does not leave a residue and quickly evaporates.
    • 3M™ Cavilon™ No Sting Barrier Film protects the skin from repeated adhesive removal.

front 13

Acrylic-based dressings

back 13

Such as 3M™ Tegaderm™, may be required for a stronger adhesion for critical tubes and are an acceptable alternative to silicone-based products.

front 14

Hydrocolloid Dressings

back 14

Such as DuoDERM®, act as both an adhesive and barrier, allowing for better adherence to curved surfaces and moisture resistance.

front 15

Precautions

Avoid the following:

back 15

  • Liquid barrier film on infants less than 30 days old
  • Alcohol-containing and organic-based adhesive due to potential for toxicity, especially to premature infants
  • Tackifiers (e.g., tincture of benzoin) because of the strong bond with the epidermis can cause epidermal stripping

front 16

Intravenous Extravasation

back 16

occurs when vesicant fluids leak into the surrounding soft tissue from a cannula or vein, leading to blistering, sloughing, and necrosis. Premature infants are at higher risk for more severe skin damage due to the immature skin, less subcutaneous tissue, and small size of their blood vessels (Bryant & Nix, 2024).

front 17

Common first signs of extravasation include

back 17

Swelling, redness or discoloration, pain, blanching, firmness, and coolness.

front 18

Extravasation Treatment

The initial steps for managing IV extravasation are as follows (Lippincott Williams & Wilkins, 2022; Tarpey, 2023):

back 18

  1. Stop infusing all medications and fluids through the venous access device. Do not flush.
  2. Disconnect the IV tubing.
  3. Do not remove the catheter or de-access the site.
  4. Attempt to aspirate the vesicant with a 1 to 3 mL syringe.
  5. Elevate and immobilize the affected extremity without applying pressure.
  6. Notify the provider and obtain further orders (e.g., antidote administration); Follow institutional procedures for extravasation.

front 19

Antidotes can be administered either through the catheter or directly into the extravasation site with a small-gauge needle (e.g., tuberculin syringe). The choice of antidote and the application of cool/warm compresses is complex and dependent on the properties of the extravasated drug, with antidotes including (Tarpey et al., 2023):

back 19

  • Hyaluronidase (Hydase®)
  • Nitroglycerin topical
  • Phentolamine (Oraverse®)
  • Sodium thiosulfate (Pedmark®)
  • Terbutaline (Brethine®)

front 20

After antidote administration and venous access removal:

back 20

  • Assess the site and outline the area of extravasation.
  • Monitor frequently for the development of complications (e.g., blistering, infection, necrosis)
  • Document in the patient EHR, including the estimated amount of vesicant infused and aspirated.
  • Document within the institutional safety management system.

front 21

Extravasation Wound Treatment

To treat extravasation wounds:

back 21

  • Use moist wound healing principles.
  • Use moisture-retentive dressings such as hydrocolloids or hydrogels.
  • Avoid massaging or applying heat to the site.

front 22

Extravasation Prevention

The following strategies help prevent intravenous extravasation (Lund & Singh, 2022):

back 22

  • Monitor the IV site hourly.
  • Apply a transparent dressing over the IV site.
  • Avoid the use of a rigid arm board.
  • Secure the arm board tape loosely and distal to the IV site.
  • Dilute IV medications to reduce potential irritation.
  • Administer dextrose solutions > 12.5% and calcium through central IV catheters only.

front 23

In neonates and children, the _____ is the most common area for development of PIs (Caillouette & Quigley, 2020). Other high-risk areas include the ear and nose, with older children and adolescents having PI patterns more similar to those of adults (e.g., sacrum and heels).

back 23

occiput

front 24

Staging for PIs in neonates and children follows the National Pressure Injury Advisory Panel (NPIAP).

back 24

See image for all 4 stages

front 25

PI Treatment

The selection of products used for PI treatment in neonates and children must take into consideration the following:

back 25

  • Approval for use in neonates and children
  • Age of the neonate or child
  • Condition of the skin
  • Potential for sensitization
  • Absorption properties of the product

front 26

PI Treatment

Commonly used commercial products include (Caillouette & Quigley, 2020):

back 26

  • Amorphous hydrogels
  • Plain or silver hydrofiber dressings
  • Thin hydrocolloids
  • Medical-grade honey
  • Silver-impregnated dressings, although there are concerns about toxicity
  • Negative pressure wound therapy (NPWT)

front 27

The ___ ____ is the preferred PI risk assessment tool for pediatric patients (Caillouette & Quigley, 2020).

back 27

Braden QD Scale

front 28

The Braden QD Scale assesses:

back 28

  • Intensity and duration of pressure, including mobility and sensory perception.
  • Tolerance of the skin and supporting structure, including friction and shear, nutritional status, tissue perfusion and oxygenation.
  • Presence of medical devices, including the number of devices and their ability to be repositioned.

front 29

Best practices in the prevention of PI in neonates and children include:

back 29

  • Using pressure redistribution products (e.g., mattresses) specifically designed for neonates and children
  • Frequently rotating pulse oximeter probes and blood pressure cuffs
  • Repositioning endotracheal tubes
  • Applying foam or gel layers between devices and skin
  • Using moisture-wicking products around tubes and skin folds
  • Ensuring tubing and cables are positioned away from the skin
  • Performing a comprehensive nutritional assessment during admission
  • Using pressure injury prevention bundles

front 30

What is the FIRST step to take when IV extravasation is suspected?.

Elevate and immobilize the extremity

Disconnect the IV tubing

Stop infusing all medications and fluids

Remove the IV catheter

back 30

Stop infusing all medications and fluids

*To prevent further tissue damage. You should NOT remove the IV catheter as it is needed for attempting aspiration of the vesicant and administering an antidote. Disconnecting the IV tubing is important, but it follows the cessation of infusion. Elevating and immobilizing the extremity is a later step aimed at reducing swelling.

front 31

Which intervention is recommended to prevent incontinence-associated dermatitis (IAD) in neonates?

Applying antiseptic creams

Daily application of talcum powder

Cleaning with isopropyl alcohol

Frequent diaper changes

back 31

Frequent diaper changes

*reduce skin moisture exposure, helping prevent incontinence-associated dermatitis. Talcum powder is not recommended for use in neonates. Topical antiseptics can delay wound healing. Isopropyl alcohol should be avoided on neonatal skin due to its potential for toxicity and irritation

front 32

Which dressing type is preferred for treating medical adhesive-related skin injuries (MARSI) in neonates?

Acrylic-based dressings

Silicone-based dressings

Silver-impregnated dressings

Medical grade honey

back 32

Silicone-based dressings

* The treatment of MARSI includes applying a silicone-based dressing to protect the area such as Mepitel. Acrylic-based dressings are used to secure critical tubes. Silver-impregnated and medical grade honey dressings are used in neonatal and pediatric wound care but are not preferred for MARSI.

front 33

Why is protein intake crucial for pediatric wound healing?

Enhances fluid balance

Aids in collagen synthesis

Increases vascularity

Promotes tissue repair

back 33

Promotes tissue repair

*Protein primarily supports tissue repair and cell growth for wound healing.

front 34

Why should products containing alcohol be avoided when treating neonatal wounds?

Increases wound drainage

Causes pH imbalance

Potential toxicity

Promotes epidermal thickening

back 34

Potential toxicity

* Alcohol-containing products are potentially toxic to neonates, as their skin permeability allows higher absorption rates than in adults.

front 35

Which treatment protocol is recommended for managing incontinence-associated dermatitis (IAD) complicated by Candida infection?

Antifungal powder, skin protectant, zinc oxide cream

Antifungal powder, zinc oxide cream, skin protectant

Zinc oxide cream, antifungal powder, skin protectant

Zinc oxide cream, skin protectant, antifungal powder

back 35

Antifungal powder, skin protectant, zinc oxide cream

The treatment protocol recommended for managing incontinence-associated dermatitis (IAD) complicated by Candida infection is antifungal powder, skin protectant, and zinc oxide cream.